| |
Ying Luo, Ph.D., President and CEO
Ying Luo joined Peking Union Medical College ( Peking
University ) in 1982 and later went to University of Connecticut
Health Center for Ph.D. degree. He did his postdoctoral
research in UCSF and later joined Aviron Company and Clontech Laboratory. He last held position
as Senior Director of Genomics in Rigel Pharmaceuticals before returning to China to found Shanghai
Genomics, Inc. He has been working on protein-protein
interaction related functional genomics technologies since
1992 and had many publications. He is also
President and COO of GNI, Ltd. and a faculty member of China Genome Center at Shanghai.
Jun Wu, Ph.D., Executive Vice President and CSO
Dr. Jun Wu is the co-founder of Shanghai Genomics Inc.
He attended Shanghai Medical University as a medical student
and later continued his undergraduate studies at San Jose
State University in the United States. In 1991, he received
his B.S. degree in Microbiology and Immunology. In 1997,
he received his doctoral degree at University of California,
San Francisco. Later, he joined DNAX Research Institute
and Rigel Pharmaceuticals. Dr. Jun Wu is an expert in
lymphocyte signal transduction and tumor immunology. He is also the Chief Scientific Officer of GNI, Ltd and an adjunct faculty member of the China National Genome Center at Shanghai.
Xiaoqing Sun, Ph.D., Senior Vice President and Head of Biology
He received Bachelor's degree from Fudan University
in 1988, majoring in Genetics and Genetic Engineering.
In 1991, he received Master's degree in Genetics from
Institute of Genetics at Fudan University. In 1992, he
moved to United States, and received Ph.D in Biochemistry
at UMDNJ-Rutgers University. Then he did his postdoctoral
research at Genentech, Inc. Now he is the vice president
of Shanghaigenomics, directing functional gene screening
and target validation.
James Yu, Ph.D., Vice President of Biotechnology
Dr. Yu received his Bachelor's degree from Nanjing University in 1986, majoring in Biochemistry. In 1989, he received a Master's degree in Cell Biology from Shanghai Institute of Cell Biology. Dr. Yu completed his Ph.D. in Microbiology and Immunology at Temple University in 1997. After his postdoctoral research at Smithkline Beecham Pharmaceuticals in Philadelphia, he joined Xenogen Corporation and held position as Senior Scientist/Project Manager before returning to China in 2005. Now he is the vice president at Shanghai Genomics.
Yi Wang, M.D./Ph.D., Vice President of Clinical Affairs
Dr. Wang received her Bachelor's degree from Shanghai Medical University in 1988, majoring in Clinical Medicine. In 1992, she received her Ph.D. in Dermatology at Shanghai Medical University. Later, she worked as a doctor in Shanghai Huadong Hospital. From 1994 she joined several pharmaceutical companies, responsible for clinical affairs, such as Schering-Plough (China) Ltd., Tianjin SmithKline and French Labs. Ltd. etc.. Now she is the vice president at Shanghai Genomics, directing clinical affairs.
|
|
|
